Sign in
CompletedNo phase

Serum Albumin Ratios Can Improve Sepsis Mortality Prediction

Key facts

Who runs it
Benha University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
30 Sept 2024
Ended
30 Dec 2024
Type of study
Observational
Treatments tested
  • serum albumin
  • C-Reactive Protein
  • Serum procalcitonin
  • Blood Lactate
Record updated
28 November 2025

Who can take part

Age
12 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients newly admitted to ICU with sepsis or septic shock
  • Patients were free of exclusion criteria

Who cannot take part

  • Patients with immunosuppressive or autoimmune disorders
  • Patients with acute kidney injury
  • Patients with hemorrhagic shock
  • Patients suspected to die in ICU

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sepsis remains a leading cause of mortality in hospitalized patients, despite advancements in critical care. Existing clinical scores for predicting sepsis outcomes often lack generalizability and complexity, hindering accurate risk assessment and timely intervention. This study aimed to evaluate the prognostic performance of serum albumin ratios to C-reactive protein (CRP), procalcitonin (PCT), and lactate in predicting 28-day morbidities and mortality in sepsis patients admitted to surgical ICUs. By incorporating these albumin ratios into clinical decision-making, we hypothesized that clinicians could more accurately identify patients at high risk of adverse outcomes and tailor treatment strategies accordingly.

The group in the trial

  • Group 1

    Patients newly admitted to ICU with sepsis or septic shock with manifestations suggestive of sepsis according to the guidelines of the 3rd International consensus definitions for sepsis and septic shock.

    Treatment: serum albumin, C-Reactive Protein, Serum procalcitonin, and Blood Lactate

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Serum Albumin Ratios Correct the Ability of Traditional Biomarkers to Predict Mortality of Sepsis Patients Admitted to Surgical ICU
Record updated
28 November 2025